AdjuderaGet started

Awarded

1ª prorroga FIBRINOGENO HUMAN0 PARENTERAL

Original language: Spanish

Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
Buyer
HOSPITAL CLINICO SAN CARLOS
Winners
CSL BEHRING, S.A, LFB BIOTERAPIAS HISPANIA, S.L., Octapharma, S.A.
Contract value
€1,008,235
Bids received
3
Published
18 Feb 2026
Awarded
18 Feb 2026
Contract start
18 Feb 2026
Contract end
7 Mar 2027estimated
Sector
Medical equipment and pharmaceuticals
Region
Madrid
Source
Original notice on TED (118705-2026)

More awards from this buyer

AwardedBuyerWinnerContract valuePublished
ATOGEPANT (AQUIPTA 60 mg comprimidos 28 comprimidos)HOSPITAL CLINICO SAN CARLOSABBVIE SPAIN, S.L€243,58828 Oct 2026
ATOGEPANT (AQUIPTA 10 mg comprimidos 28 comprimidos)HOSPITAL CLINICO SAN CARLOSABBVIE SPAIN, S.L€12,99128 Oct 2026
FILSPARI 400 MG COMPRIMIDOS 30 comprimidosHOSPITAL CLINICO SAN CARLOSVIFOR PHARMA ESPAÑA S.L.€253,39428 Oct 2026
FILSPARI 200 MG COMPRIMIDOS 30 comprimidosHOSPITAL CLINICO SAN CARLOSVIFOR PHARMA ESPAÑA S.L.€9,70428 Oct 2026
2ª prorroga RINGER LACTADO SOLUCIÓN ESTÉRIL Y APRIRÓGENA EN AGUA PARA INYECCIÓN FRASCO PLÁSTICO SEMIRRÍGIDO O BOLSA PLASTICOHOSPITAL CLINICO SAN CARLOSFRESENIUS KABI ESPAÑA, S.A.€17,39023 Oct 2026
2ª prorroga GLUCOSALINO SOLUCIÓN ESTÉRIL Y APRIRÓGENA EN AGUA PARA INYECCIÓN ADMINISTRACIÓN IV FRASCO PLÁSTICO SEMIRRÍGIDO O BOLSA PLASTICOHOSPITAL CLINICO SAN CARLOSFRESENIUS KABI ESPAÑA, S.A.€4,88023 Oct 2026